[Complete Remission of Metastatic Renal Cell Carcinoma with Invasion of the Duodenum and Pancreas after Treatment with Nivolumab Plus Ipilimumab Followed by Axitinib and Surgery : A Case Report]

Hinyokika Kiyo. 2021 May;67(5):197-203. doi: 10.14989/ActaUrolJap_67_5_197.
[Article in Japanese]

Abstract

A man in his 60s was diagnosed with clear cell carcinoma of the right kidney with multiple lung metastases, tumor thrombus of the inferior vena cava (IVC), and invasion of the duodenum and pancreas. Ipilimumab plus nivolumab was administered as first-line therapy. After 3 treatment courses, computed tomography (CT) demonstrated a slight decrease in the size of the primary tumor and lung metastases. However, the patient became hemodynamically unstable due to persistent duodenal bleeding during treatment despite frequent blood transfusions. Axitinib was then initiated as second-line therapy. The duodenal bleeding ceased 10 days after starting axitinib and his anemia remissed. Subsequent CT showed further decrease in the size of the primary tumor and lung metastases. The patient underwent right nephrectomy after improvement of nutrition. IVC thrombectomy, and pancreaticoduodenectomy. The lung metastases disappeared on postoperative imaging and no additional treatment was provided. Twelve months after surgery, he was in good health and showed no signs of recurrence.

Publication types

  • Case Reports

MeSH terms

  • Axitinib
  • Carcinoma, Renal Cell* / drug therapy
  • Carcinoma, Renal Cell* / surgery
  • Duodenum
  • Humans
  • Ipilimumab / therapeutic use
  • Kidney Neoplasms* / drug therapy
  • Kidney Neoplasms* / surgery
  • Male
  • Neoplasm Recurrence, Local
  • Nephrectomy
  • Nivolumab / therapeutic use
  • Pancreas
  • Thrombectomy
  • Vena Cava, Inferior

Substances

  • Ipilimumab
  • Nivolumab
  • Axitinib